What Is 2-isopropylmalate synthase

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 2-Isopropylmalate synthase (2-IPMS) is an enzyme that catalyzes the first committed step in leucine biosynthesis, combining acetyl-CoA and α-ketoisovalerate to form 2-isopropylmalate. It is found in bacteria, archaea, and plants, but not in animals, making it a potential antimicrobial drug target. The enzyme's structure and mechanism were first characterized in detail in the 1990s using Escherichia coli and Mycobacterium tuberculosis models.

Key Facts

2-Isopropylmalate synthase catalyzes the first step in leucine biosynthesis with a rate constant of ~0.7 s⁻¹ in E. coli.
The enzyme is absent in mammals, making it a promising target for antibiotic development.
Crystal structures of 2-IPMS from Mycobacterium tuberculosis were solved in 2006 and 2010.
2-IPMS requires a divalent metal ion, typically Mg²⁺ or Mn²⁺, for catalytic activity.
The gene encoding 2-IPMS is often designated leuA in bacterial genomes.

Overview

2-Isopropylmalate synthase (2-IPMS) is a key regulatory enzyme in the biosynthetic pathway of the essential amino acid leucine. It catalyzes the condensation of acetyl-CoA and α-ketoisovalerate to form 2-isopropylmalate, initiating the three-step leucine synthesis cascade found in bacteria, archaea, and plants.

Unlike mammals, which obtain leucine from dietary sources, microorganisms must synthesize it internally, making 2-IPMS a critical metabolic enzyme in these organisms. Its absence in humans makes it an attractive target for the development of selective antimicrobial agents.

Enzyme classification: 2-IPMS is classified as EC 2.3.3.13, belonging to the citrate synthase superfamily of enzymes that catalyze Claisen-type condensations.
Substrate specificity: The enzyme shows high specificity for acetyl-CoA and α-ketoisovalerate, with Km values of approximately 0.1 mM and 0.05 mM, respectively, in E. coli.
Regulatory role: 2-IPMS is allosterically inhibited by the end product of the pathway, leucine, with IC50 values ranging from 10 to 50 μM depending on the organism.
Gene name: In most bacteria, the gene encoding this enzyme is known as leuA, and mutations in leuA can lead to leucine auxotrophy.
Evolutionary conservation: Homologs of 2-IPMS are found in over 85% of sequenced bacterial genomes, indicating its fundamental role in microbial metabolism.

How It Works

2-Isopropylmalate synthase operates through a multi-step mechanism involving metal ion coordination and nucleophilic attack, typical of CoA-utilizing enzymes. The reaction proceeds via the formation of an enzyme-bound enolate intermediate that attacks the carbonyl carbon of α-ketoisovalerate.

Reaction type: The enzyme catalyzes a Claisen condensation, forming a carbon-carbon bond between acetyl-CoA and α-ketoisovalerate, releasing CoA-SH in the process.
Metal ion dependence: Requires a divalent cation such as Mg²⁺ or Mn²⁺ for activity, with Mg²⁺ being the physiologically relevant cofactor in most organisms.
Catalytic residues: Key residues like lysine 260 and aspartate 213 in E. coli facilitate proton abstraction and stabilize reaction intermediates.
Inhibition mechanism: Leucine binds to an allosteric site, inducing a conformational change that reduces substrate affinity by up to 90% in some species.
Structural domains: The enzyme typically has two domains: an N-terminal catalytic domain and a C-terminal regulatory domain that binds leucine.
Reaction rate: Turnover number (k_cat) for 2-IPMS in Salmonella typhimurium is approximately 0.7 s⁻¹, indicating moderate catalytic efficiency.

Comparison at a Glance

Enzymatic properties of 2-isopropylmalate synthase across different organisms:

Organism	Gene	Leucine Inhibition	Metal Preference	Optimal pH
Escherichia coli	leuA	Yes (IC50 ~20 μM)	Mg²⁺	7.5
Mycobacterium tuberculosis	leuA1	Yes (IC50 ~15 μM)	Mn²⁺	7.0
Thermus thermophilus	leuA	Yes	Mg²⁺	8.0
Arabidopsis thaliana	At5g10040	Yes	Mg²⁺	7.8
Saccharomyces cerevisiae	LEU4/LEU9	Yes (partial)	Mg²⁺	7.2

Despite variations in sequence and metal preference, all forms of 2-IPMS maintain leucine-dependent feedback inhibition, underscoring the evolutionary importance of regulating leucine biosynthesis. Structural studies show conserved active site architecture, even in distantly related species, suggesting strong selective pressure to maintain function.

Why It Matters

Understanding 2-isopropylmalate synthase has significant implications for biotechnology and medicine, particularly in the fight against antibiotic-resistant pathogens. Because the enzyme is absent in humans, targeting it offers a pathway for selective inhibition without harming host cells.

Antibiotic development: Inhibitors of 2-IPMS could serve as novel antibiotics, especially against Mycobacterium tuberculosis, where leucine biosynthesis is essential for survival.
Herbicide design: Since plants use 2-IPMS, engineered inhibitors could lead to selective herbicides that do not affect animals.
Metabolic engineering: Modifying 2-IPMS regulation allows for overproduction of leucine in industrial fermentation processes.
Drug resistance: Mutations in leuA can confer resistance to potential drugs, highlighting the need for combination therapies.
Structural biology: The enzyme's conformational changes upon leucine binding provide insights into allosteric regulation mechanisms.
Evolutionary studies: 2-IPMS sequence divergence helps trace metabolic evolution across domains of life.

As research continues, 2-isopropylmalate synthase remains a model system for studying enzyme kinetics, feedback inhibition, and drug targeting in microbial metabolism.